Nasdaq Biotech Index mit Mega-Kaufsignal: BB-Biotech-Beteiligungen extrem stark

Die lange Phase der Konsolidierung beim Nasdaq Biotech Index seit dem Hoch im Jahr 2015 scheint ein Ende gefunden zu haben.
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
668